TIFFANY FLORENCE: Open Payments
NPI 1538526157 · ORANGE PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$742 in 11 payments from 7 companies in 2025. Trend: 2023 $3,839 · 2024 $859 · 2025 $742
Food & beverage: $742
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $250 |
| Insmed, Inc. | 2 | $168 |
| Lilly USA, LLC | 1 | $125 |
| Actelion Pharmaceuticals US, Inc. | 1 | $102 |
| INOGEN, INC. | 2 | $44 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| GENZYME CORPORATION | 1 | $14 |
Products named: TEZSPIRE, Arikayce, ZEPBOUND, UPTRAVI, INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH, NUCALA, DUPIXENT.
Industry payments across FL — which companies pay providers there.
